TriSalus Life Sciences, Inc. (TLSI)
(Delayed Data from NSDQ)
$4.21 USD
+0.01 (0.24%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $4.20 -0.01 (-0.24%) 5:36 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
TriSalus Life Sciences, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Products industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
TLSI 4.21 +0.01(0.24%)
Will TLSI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TLSI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TLSI
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates
OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)
TLSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
TerrAscend Corp. (TSNDF) Reports Q1 Loss, Lags Revenue Estimates
SurModics (SRDX) Reports Q2 Loss, Misses Revenue Estimates
Other News for TLSI
TriSalus Life Sciences to Participate in the Canaccord Genuity 45th Annual Growth Conference | ...
TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference Call | TLSI ...
TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent ...
TriSalus Life Sciences management to meet virtually with Lake Street
Lake Street Keeps Their Buy Rating on TriSalus Life Sciences (TLSI)